• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高血液相容性:智能表面如何引导血液对抗血栓。

Improving Hemocompatibility: How Can Smart Surfaces Direct Blood To Fight against Thrombi.

机构信息

DWI - Leibniz-Institute for Interactive Materials e.V., Forckenbeckstraße 50, Aachen D-52074, Germany.

Institute of Technical and Macromolecular Chemistry, RWTH Aachen University, Forckenbeckstraße 50, Aachen D-52074, Germany.

出版信息

ACS Appl Mater Interfaces. 2021 Mar 17;13(10):11696-11707. doi: 10.1021/acsami.1c01079. Epub 2021 Mar 3.

DOI:10.1021/acsami.1c01079
PMID:33656864
Abstract

Nature utilizes endothelium as a blood interface that perfectly controls hemostasis, preventing the uncontrolled formation of thrombi. The management of positive and negative feedback that finely tunes thrombosis and fibrinolysis is essential for human life, especially for patients who undergo extracorporeal circulation (ECC) after a severe respiratory or cardiac failure. The exposure of blood to a surface different from healthy endothelium inevitably initiates coagulation, drastically increasing the mortality rate by thromboembolic complications. In the present study, an ultrathin antifouling fibrinolytic coating capable of disintegrating thrombi in a self-regulated manner is reported. The coating system is composed of a polymer brush layer that can prevent any unspecific interaction with blood. The brushes are functionalized with a tissue plasminogen activator (tPA) to establish localized fibrinolysis that solely and exclusively is active when it is required. This interactive switching between the dormant and active state is realized through an amplification mechanism that increases (positive feedback) or restores (negative feedback) the activity of tPA depending on whether a thrombus is detected and captured or not. Thus, only a low surface density of tPA is necessary to lyse real thrombi. Our work demonstrates the first report of a coating that self-regulates its fibrinolytic activity depending on the conditions of blood.

摘要

自然界利用内皮细胞作为血液界面,完美地控制止血,防止血栓的失控形成。精细调节血栓形成和纤维蛋白溶解的正反馈和负反馈的管理对于人类生命至关重要,特别是对于那些在严重呼吸或心脏衰竭后接受体外循环 (ECC) 的患者。血液与不同于健康内皮细胞的表面接触不可避免地会引发凝血,血栓栓塞并发症使死亡率大幅增加。在本研究中,报道了一种超薄的抗污溶血栓涂层,能够以自我调节的方式分解血栓。该涂层系统由聚合物刷层组成,可防止与血液发生任何非特异性相互作用。刷子用组织型纤溶酶原激活剂 (tPA) 进行功能化,以建立局部纤维蛋白溶解,只有在需要时才具有活性。这种休眠和激活状态之间的交互切换是通过一种放大机制实现的,该机制根据是否检测到并捕获血栓来增加 (正反馈) 或恢复 (负反馈) tPA 的活性。因此,只有低表面密度的 tPA 就足以溶解真正的血栓。我们的工作首次报道了一种涂层,它可以根据血液条件自我调节其纤维蛋白溶解活性。

相似文献

1
Improving Hemocompatibility: How Can Smart Surfaces Direct Blood To Fight against Thrombi.提高血液相容性:智能表面如何引导血液对抗血栓。
ACS Appl Mater Interfaces. 2021 Mar 17;13(10):11696-11707. doi: 10.1021/acsami.1c01079. Epub 2021 Mar 3.
2
Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.南方铜头蛇毒液可增强组织型纤溶酶原激活剂诱导的纤维蛋白溶解,但不会直接溶解人血浆血栓。
J Thromb Thrombolysis. 2016 Jul;42(1):33-7. doi: 10.1007/s11239-015-1287-2.
3
Novel and emerging therapies: thrombus-targeted fibrinolysis.新型和新兴疗法:血栓靶向纤维蛋白溶解。
Semin Thromb Hemost. 2013 Feb;39(1):48-58. doi: 10.1055/s-0032-1328935. Epub 2012 Oct 3.
4
Tissue plasminogen activator-containing polyurethane surfaces for fibrinolytic activity.含组织型纤溶酶原激活剂的聚氨酯表面的纤维蛋白溶解活性。
Acta Biomater. 2011 May;7(5):1993-8. doi: 10.1016/j.actbio.2011.01.026. Epub 2011 Jan 21.
5
Microfluidic Modeling of Thrombolysis.微流控溶栓模型。
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2626-2637. doi: 10.1161/ATVBAHA.118.311178.
6
Steps Toward Recapitulating Endothelium: A Perspective on the Next Generation of Hemocompatible Coatings.迈向内皮细胞再生:下一代血液相容性涂层的展望。
Macromol Biosci. 2024 Oct;24(10):e2400152. doi: 10.1002/mabi.202400152. Epub 2024 Jul 29.
7
Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.血浆组织型纤溶酶原激活物可增强外源性尿激酶型纤溶酶原激活物的纤溶活性。
Blood Coagul Fibrinolysis. 2012 Dec;23(8):729-33. doi: 10.1097/MBC.0b013e32835897d5.
8
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.急性缺血性心脏病患者的纤维蛋白溶解。特别提及组织型纤溶酶原激活剂治疗对纤维蛋白溶解、凝血和补体途径的全身影响。
Dan Med Bull. 1993 Sep;40(4):383-408.
9
Interactions of fibrinolytic system proteins with lysine-containing surfaces.纤维蛋白溶解系统蛋白与含赖氨酸表面的相互作用。
J Biomed Mater Res A. 2003 Sep 15;66(4):795-801. doi: 10.1002/jbm.a.10017.
10
Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.在动脉血流条件下,通过纤溶药物对壁血小板沉积物溶解情况的实时测量。
Ann Biomed Eng. 1998 Jul-Aug;26(4):712-24. doi: 10.1114/1.46.

引用本文的文献

1
Enhancing Hemocompatibility in ECMO Systems With a Fibrinolytic Interactive Coating: in Vitro Evaluation of Blood Clot Lysis Using a 3D Microfluidic Model.通过纤维蛋白溶解交互式涂层增强体外膜肺氧合系统的血液相容性:使用3D微流控模型对血凝块溶解的体外评估。
Macromol Biosci. 2025 May;25(5):e2400530. doi: 10.1002/mabi.202400530. Epub 2025 Jan 13.
2
Engineered endothelium-mimicking antithrombotic surfaces via combination of nitric oxide-generation with fibrinolysis strategies.通过一氧化氮生成与纤维蛋白溶解策略相结合构建仿内皮抗血栓表面。
Bioact Mater. 2024 Sep 27;43:319-329. doi: 10.1016/j.bioactmat.2024.09.011. eCollection 2025 Jan.
3
Strategies for surface coatings of implantable cardiac medical devices.
植入式心脏医疗设备的表面涂层策略。
Front Bioeng Biotechnol. 2023 May 9;11:1173260. doi: 10.3389/fbioe.2023.1173260. eCollection 2023.
4
A guide to functionalisation and bioconjugation strategies to surface-initiated polymer brushes.表面引发聚合物刷的功能化和生物偶联策略指南。
Chem Commun (Camb). 2023 Jun 15;59(49):7534-7558. doi: 10.1039/d3cc01082a.